ARCHIVES

In Brief: Online Genetics Glossary; ORI Misconduct Finding

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

ASCO: NCI Authorities Still Important

June 11, 2010

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

Proposed Criteria For Establishing Carcinogenicity Listed

November 21, 1975

European Commission Approves Subcutaneous Rituximab

March 28, 2014

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997